A‑Ret HC Cream blends hydroquinone, tretinoin, and hydrocortisone into a prescription-strength topical treatment targeting hyperpigmentation, melasma, and uneven skin tone. While hydroquinone lightens dark spots, tretinoin boosts cell turnover and hydrocortisone soothes potential irritation—delivering effective results when used short-term under dermatologist supervision.
Select options
This product has multiple variants. The options may be chosen on the product page
Eukroma Cream 20 g is a topical depigmenting treatment featuring hydroquinone, an established agent for fading dark spots, melasma, and hyperpigmentation. It works by slowing melanin production to promote a more balanced, even skin tone. Intended for short-term use under clinical supervision, consistent application can yield visible reduction in discoloration.
Select options
This product has multiple variants. The options may be chosen on the product page
Eukroma KJ Cream 20 gm is a topical skin-lightening formulation combining hydroquinone (2 %) and kojic acid (2 %) to reduce melasma, sun spots, and dark patches. Hydroquinone helps inhibit melanin production while kojic acid enhances lightening. This combination improves tone and clarity with nourishing emollients for safe, localized use.
Select options
This product has multiple variants. The options may be chosen on the product page
Flucort S Skin Lotion 30 ml contains fluocinolone acetonide, a mild-to-moderate corticosteroid lotion used to treat inflammatory skin conditions including eczema, dermatitis, and mild psoriasis. The lightweight lotion base absorbs quickly to reduce itching, redness, and irritation while providing soothing moisture without greasiness.
Select options
This product has multiple variants. The options may be chosen on the product page
HyDe Solution is a topical formula with 2% hydroquinone, designed to fade dark spots, post-acne pigmentation, and hyperpigmented patches. Ideal for precision spotting on localized areas, it works by inhibiting melanin production, promoting a more uniform skin tone. Recommended for short-term use under dermatologist supervision and complemented by consistent sun protection
Select options
This product has multiple variants. The options may be chosen on the product page
Magnalyte Cream (15 g) features a synergistic blend of hydroquinone (depigmenter), tretinoin (retinoid exfoliant), and fluocinonide (anti-inflammatory corticosteroid) designed to treat melasma, stubborn dark spots, and post-inflammatory hyperpigmentation. The formula accelerates skin turnover, inhibits excess melanin production, and soothes inflammation—supporting clearer, more even-toned skin when used short term under medical supervision.
Select options
This product has multiple variants. The options may be chosen on the product page
Magnalyte‑Plus Cream is a prescription topical formula combining hydroquinone (depigmenting agent), tretinoin (retinoid for skin renewal), and fluocinonide (corticosteroid for inflammation control). This powerful tri-combination addresses melasma, sun spots, and post-inflammatory pigmentation while supporting exfoliation and reducing irritation. It is intended for short-term use under medical supervision to balance efficacy with tolerability.
Select options
This product has multiple variants. The options may be chosen on the product page
Melacare Cream is a prescription-strength topical product featuring a combination of hydroquinone (depigmenting agent), tretinoin (skin-renewing retinoid), and mometasone (anti-inflammatory corticosteroid). This powerful formula addresses dark spots, melasma, and uneven tone while supporting exfoliation and calming irritation. Designed for short-term dermatological use to balance efficacy with skin comfort.
Select options
This product has multiple variants. The options may be chosen on the product page
Melalite Forte Cream is a prescription-grade topical treatment formulated with hydroquinone, widely used to reduce hyperpigmentation, melasma, and sun-induced dark spots. It inhibits melanin production to deliver a more even complexion. Intended for short-term use under dermatological supervision, results usually begin to appear after consistent application over several weeks.
Select options
This product has multiple variants. The options may be chosen on the product page
Melanorm Cream is a prescription topical formulation containing hydroquinone, an established agent for treating hyperpigmentation, melasma, sun spots, and uneven skin tone. It works by inhibiting melanin formation to lighten affected areas and promote a more uniform complexion. Intended for use under dermatologist supervision, the cream should be applied consistently over several weeks for visible results.
Select options
This product has multiple variants. The options may be chosen on the product page
Skinlite Cream is a prescription-strength topical formulation that blends hydroquinone, tretinoin, and mometasone to treat stubborn melasma, hyperpigmentation, and skin discoloration. Hydroquinone works to lighten pigment, tretinoin increases skin turnover, and mometasone reduces inflammation—delivering comprehensive and controlled depigmentation for targeted areas.
Select options
This product has multiple variants. The options may be chosen on the product page
Skinshine Cream is a prescription-strength topical blend of hydroquinone, tretinoin, and mometasone used to treat melasma, dark spots, and uneven skin tone. Hydroquinone reduces pigmentation, tretinoin promotes skin cell turnover, and mometasone helps decrease inflammation—resulting in multifaceted pigmentation control when used short-term under medical supervision.
Select options
This product has multiple variants. The options may be chosen on the product page
End of content
End of content
Join our newsletter and get 20% off your first order
Subscribe to our newsletter and get the latest trending products and offers updates.
Wait! before you leave…
We have something special for you
Use above code to get 20% off for your first order when checkout. Don't miss it.
In order to provide you a personalized shopping experience, our site uses cookies. By continuing to use this site, you are agreeing to our cookie policy.